Theme: Insight into the advances in Radiology & Oncology

RADIOLOGY AND ONCOLOGY 2022

RADIOLOGY AND ONCOLOGY 2022

We are delighted to extend an invitation on behalf of the scientific committee to the 6th Global Meeting on Oncology and Radiology, which will be held in Madrid, Spain on November 07-08, 2022. "Insight into the advances in Radiology & Oncology" is the theme of the Radiology and Oncology 2022 conference, which includes a wide range of vitally important sessions in the fields of Oncology, Radiology, Cancer, and Imaging. All elements of cancer imaging and intervention will be covered in this interdisciplinary multi-specialty oncology course. The goal of this gathering is to provide the most up-to-date information on radiology as well as innovative cancer treatment alternatives. We will bring together academics and young scientists from all around the world.

Why to Attend?

Radiology and Oncology 2022 is a forum where specialists, authorities, and CROs from all over the world may debate. It's your chance to be a part of Radiology and Oncology 2020's group of Speakers, discussions, Delegates, Posters, video proposals, Business Meetings, Networking, and additional perks for our Event Sponsor. This conference will include the most up-to-date methodologies, upgrades, new ideas, and research updates in the fields of cancer and radiopharmaceuticals.

Who Attends?

  • Oncologists
  • Radiologists
  • Radiation Oncologists
  • Radiology Consultants
  • Radiology and oncology Doctors
  • Cancer therapists
  • Radiographers  and Radiology Technologists
  • Healthcare professionals
  • Research Scholar
  • Founders and Employees of the related companies
  • Clinical investigators & Researcher
  • Hospitals and Health Services
  • Pharmaceutical companies
  • Laboratory members
  • Students
  • Support organizers
  • Educators, Scientists, and Researchers
  • Business Professionals
  • Directors of Oncology and Radiology or related Programs or Associations
  • Heads, Deans and Professors of Radiology and Oncology department

Track 1: Radiology Trends and Technology

Radiology is the science that analyses diagnoses and, in certain cases, treats disorders inside the body using restorative imaging. To diagnose or potentially cure infections, a variety of imaging methods are used, including X-ray radiography, ultrasound, computed tomography (CT), atomic radiation including Positron Emission Tomography (PET), and magnetic resonance imaging (MRI). Interventional radiology is the application of (usually minimally invasive) treatment techniques under the guidance of imaging advances.

The radiographer, also known as a Radiologic Technologist, is usually in charge of securing restorative images. The Diagnostic Radiologist, or Reporting Radiographer, next interprets or "peruses" the images and offers a report on their findings, impressions, or conclusions, depending on the area.

  • Global radiology
  • Medical radiography
  • Radiation protection
  • Fluoroscopy
  • Pediatric Radiology

Track 2: Radiopharmaceuticals

A radiopharmaceutical is a medication that may be used for both diagnosis and treatment. This is a unique type of medicine that combines a radioactive molecule with a radioactive molecule. A radioactive isotope is used in radiopharmaceuticals. Radioisotopes attach to biological molecules that can be used to target specific organs, tissues, or cells in the body. These radioactive medications can be used for illness diagnosis and, in certain cases, treatment. The use of radiopharmaceuticals in clinical practise is quickly rising, providing the medical community with more specific knowledge and information about the features of various types of malignancies.

  • High objective: non-objective acceptance ratio
  • Toxicity

Track 3:  Cancer & Therapeutics

Cancer Therapeutics aims to address the challenges of tumour heterogeneity, cancer development, and drug resistance by utilising a growing number of technologies available to doctors in the treatment of this illness. It has gone through a paradigm shift away from classic cytotoxic medications and toward targeting proteins that are fundamental to the cancer phenotype. The discovery and development of HSP90 inhibitors has been sought by cancer therapies as a means of avoiding or overcoming medication resistance. All anticancer drugs work by inhibiting cell growth or normal function, DNA synthesis, and RNA and protein metabolite blocking or alteration.

  • Cancer stem cells
  • Kinase inhibitors
  • Personalised medicine
  • Protein–protein interactions

Track 4:  Neuroradiology and Neuro Oncology

Neuroradiology focuses on the use of neuroimaging methods and radiology to analyse and characterise disorders of the peripheral and central nervous systems, spine, and head and neck. The enhancement of MR imaging of brain and spinal cord neoplasms is one of the most recent advancements in the research domains of Neuroradiology. Computed tomography and magnetic resonance imaging are two important imaging techniques. Individuals in the paediatric population utilise ultrasound and plain radiography on a limited basis and in restricted circumstances. Neuro oncology refers to a variety of malignant neurologic illnesses, including astrocytoma, glioblastoma multiforme, ependymoma, pontine glioma, and brain stem tumours, as well as brain and spinal cord neoplasms, many of which are extremely hazardous and life-threatening.

  • Clinical radiation oncology
  • Radioactive compounds in neuroimaging
  • Molecular radiation oncology
  • Cellular radiation oncology
  • Palliative radiotherapy in neuro oncology

Track 5: Radiotherapy and Chemotherapy

Radiotherapy is a sort of cancer treatment that use high energy beams to destroy cancer cells. X-rays are commonly employed, although protons or other sources of energy can also be used. Radiation therapy is a type of treatment that employs radiation waves such as light or heat to treat cancers and other tumours and diseases. It causes harm to cells by damaging the genetic material that regulates cell growth and division. Chemotherapy is a medicinal treatment that employs strong chemicals to destroy fast-growing cells in your body. It is most commonly used to treat cancer since cancer cells grow and multiply considerably faster than most cells in the body.

  • Adjuvant therapy
  • External beam radiation therapy
  • Radiation oncology
  • Chemotherapy regimen

Track 6: Oncology Nursing and Care

Nursing is a health-care profession that focuses on providing care to individuals and societies so that they can achieve, maintain, or improve their well-being and quality of life. Nurses develop a care plan in partnership with doctors, therapists, the patient, the patient's family, and other members of the organisation that focuses on treating the condition and improving the patient's quality of life. An oncology nurse is a nurse who specialises in treating cancer patients. Oncology nursing care is described as meeting the different requirements of oncology patients throughout their disease, including sufficient screening and other preventative procedures, symptom management, care to preserve the best possible level of normal functioning, and end-of-life measures of support.

  • Chemotherapy and biotherapy
  • Nursing Informatics

Track 7: Magnetic Resonance Imaging (MRI)

In both health and sickness, magnetic resonance imaging is used to assess the anatomy and physiology of the body. MRI scanners generate images of the organs in the body using strong magnetic fields, magnetic field gradients, and radio waves, and are based on sophisticated technology that excites and detects changes in the direction of the rotational axis of protons found in the water that makes up living tissues. It can be used to diagnose or track the progress of treatment for a number of chest, abdominal, and pelvic diseases.

  • Tumor Heterogeneity
  • Inter- intra tumour heterogeneity
  • Claustrophobia
  • Ionizing radiation of x-rays

Track 8: Cancer Cell Biology and Cancer Biomarker

Cancer cells develop incessantly, producing solid tumours or infiltrating the bloodstream with aberrant cells. Cell biology includes both prokaryotic and eukaryotic cells and may be broken down into a variety of sub-topics, such as cell metabolism, cell communication, cell cycle, biochemistry, and cell composition. The human body is made up of cells, which are the simplest and smallest units of life. Cell biology is the scientific study of cells. A tumour is a mass formed by certain cells. Cancer Biomarkers, also known as molecular markers, are biological molecules such as DNA, RNA, and proteins, as well as genes and processes like as apoptosis and proliferation that may be used to identify a disease, condition, or other anomalies in the body.

  • Cancerous cells
  • Cell lung cancer
  • Cervical cancer
  • Benign tumor

Track 9: Medical Imaging Technology

Medical imaging is the technique of creating a visual portrayal of the interior of a body for medical intervention and clinical analysis, as well as visual representation of the function of some organs or tissues, to make it possible to identify abnormalities. It is also the technique of creating a database of normal anatomy and physiology to make it possible to identify abnormalities. Imaging for therapeutic purposes is managed by a team of radiologists, radiographers, sonographers, medicinal physicists, biomedical designers, and other support professionals who work together to improve the well-being of patients one by one. The proper use of medical imaging necessitates a multidisciplinary approach.

  • Medical ultrasonography
  • Radiography
  • Biological imaging
  • Endoscopy

Track 10: Cancer Pharmacology

Cancer pharmacology is a peer-reviewed medical journal that focuses on the basic mechanisms of signal transduction involved in cell proliferation and apoptosis (cell programme death), the mechanisms of action of antineoplastic agents, the design and development of new drugs, and the basic mechanisms of DNA repair and cell damage tolerance. DNA and the development of gene therapy techniques the categorization and characterization of fundamental cell signalling pathways that establish targets for chemicals used in cancer therapy, as well as DNA destruction and repair mechanisms that offer resistance to antineoplastic medicines, are of critical importance.

  • Proto-oncogenes
  • Gene therapy

Track 11: Cancer Prevention and Research

Cancer research and study to identify causes and create advanced prevention, inhibition, diagnostic, medicine, therapies, and cure options. Surgery, radiation, chemotherapy, hormonal therapy, immunotherapy, and integrated therapy, as well as therapeutic methods such as chemo-radiotherapy and radiotherapy, are among the uses. Cancer prevention is a strategy for lowering the chance of developing cancer. Maintaining a healthy lifestyle, avoiding exposure to known cancer-causing chemicals, and using cancer-prevention drugs or vaccinations are all examples of this.

  • Weight loss
  • Alcohol consumption

Track 12: Interventional Radiology

Interventional radiology, also known as vascular and interventional radiology (VIR), is a medical specialty that provides minimally invasive image-guided diagnosis and treatment of disease procedures using medical imaging guidance, such as x-ray fluoroscopy, computed tomography, magnetic resonance imaging, or ultrasound. Although interventional radiologists undertake a wide range of treatments, the common thread running through them all is the use of image guidance and minimally invasive approaches to reduce patient risk.

  • Carpal tunnel ultrasound and injection
  • Image-guided liver biopsy
  • Bursal injection

The Market Analysis Report of Radiology and Oncology is expected to reach USD 25.50 Billion by 2022 from USD 17.99 Billion in 2017. The market is broadly classified into product, procedure type, and application.

The product segment of the market is further divided into Radiography system, angiography systems, fluoroscopy systems, CT scanners, ultrasound-imaging systems, MRI systems, and other medical devices.

Radiology and Oncology markets continue to grow amid a more educated global population, increased awareness and advanced technology used for Disease diagnostics. 

                             

The number of new cancer cases diagnosed every year is increased from 14.9 million of 2012 to 25.50 million by 2022. The expansion in new cases is because of a steadily aging population. Both developed and developing countries have maturing or growing population.

Innovation and technology enhances the accuracy and appropriateness of radiotherapy and radiosurgery.  Large number uses of Radiotherapy and radiosurgery equipment’s occur because the units are able to treat a broader range of cases. Advances in equipment and programming are providing a business opportunity replacing an aging installed base. New designs and outlines can convey high standards of care.

The rise in cancer cases, together with the expansion in sophistication of new treatment etiquette, has made interest for more automated products. Automation relies upon incorporation of a few devices into clinically useful frameworks. Coordinated frameworks make medications quick and practical.

Innovation progresses prompt enhancements in patient care. The accessibility of advanced, mechanized and productive clinical apparatuses in radiation therapy has brought more exact types of radiotherapy treatment (IMRT, IGRT, VMAT, SRS, SBRT, brachytherapy and proton treatment). Innovation and Technology  incorporates the EDGE™ and Truebeam™, and the Accuray TomoTherapy H Series and CyberKnife M6 stages that empower medications that diminish treatment times and increment persistent throughput.

 

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date November 07-08, 2022
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View